Journals / Türk Onkoloji Dergisi / 2008 / Cilt: 23 - Sayı: 2

Detection of bone marrow micrometastases by reverse-transcriptase polymerase chain reaction (RT-PCR) in patients with early breast cancer

Erken evre meme kanserinde revers transkriptaz polimeraz zincir reaksiyonu (RT-PCR) tekniği ile kemik iliği mikrometastazlarının araştırılması

Pages
55–62
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

No statistically significant associations could be found between DF3-positivity and other parameters including stage, tumor size (2 cm), axillary involvement, ER/PR positivity, and high histologic or nuclear grade.CONCLUSION Our results suggest that testing DF3 expression by RT-PCR technique seems to be a reliable method in detection of micrometastatic cells in bone marrow in patients with early breast cancer because of its high specificity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVES The aim of this study was to determine the feasibility of a molecular assay by investigating cytokeratin 19 (CK-19) and DF3 gene expressions in detection of occult cancer cells in bone marrow in patients with breast cancer.
📊
Key Findings & Data:METHODS Transcriptase-polymerase chain reaction (RT-PCR) assays were carried out for the detection of CK19 and DF3 mRNA transcripts in bone marrow samples of 28 clinically axillary negative patients with early breast cancer.RESULTS Median age of patients was 47.5 (range, 32-86).
💡
Conclusion & Impact:No statistically significant associations could be found between DF3-positivity and other parameters including stage, tumor size (2 cm), axillary involvement, ER/PR positivity, and high histologic or nuclear grade.CONCLUSION Our results suggest that testing DF3 expression by RT-PCR technique seems to be a reliable method in detection of micrometastatic cells in bone marrow in patients with early breast cancer because of its high specificity.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVES The aim of this study was to determine the feasibility of a molecular assay by investigating cytokeratin 19 (CK-19) and DF3 gene expressions in detection of occult cancer cells in bone marrow in patients with breast cancer. METHODS Transcriptase-polymerase chain reaction (RT-PCR) assays were carried out for the detection of CK19 and DF3 mRNA transcripts in bone marrow samples of 28 clinically axillary negative patients with early breast cancer.RESULTS Median age of patients was 47.5 (range, 32-86). Due to the high false positivity rate of the CK19-RT-PCR assay, and negative findings by the DF3-RT-PCR assay in bone marrow samples of patients with chronic myelogenous leukemia as negative controls, DF3 expression was tested in further RT-PCR assays. E i g hteen patients (64%) were found to harbor DF3-positivity in bone marrow samples. No statistically significant associations could be found between DF3-positivity and other parameters including stage, tumor size (2 cm), axillary involvement, ER/PR positivity, and high histologic or nuclear grade.CONCLUSION Our results suggest that testing DF3 expression by RT-PCR technique seems to be a reliable method in detection of micrometastatic cells in bone marrow in patients with early breast cancer because of its high specificity.

Özet

AMAÇ Meme kanserinde kemik iliği mikrometastazı saptanmasında sitokeratin 19 (CK19) ve DF3 gen ekspresyonlarının araştırıldığı moleküler bir yöntemin etkinliğini değerlendirmektir. GEREÇ VE YÖNTEM Klinik olarak aksilla negatif olan 28 erken evre meme kanserli hastadan alınan kemik iliği aspiratlarında revers transkriptaz polimeraz zincir reaksiyonu (RT-PCR) tekniğiyle CK19 ve DF3 genlerine özgü iki ayrı primer kullanılarak mikrometastatik kanser hücresi araştırıldı.BULGULAR Hastaların ortanca yaşı 47,5'tir (32-86). RT-PCR çalışmalarında negatif kontrol olarak kullanılan kronik miyeloid lösemili kemik iliği örneklerinin keratin 19 ekspresyonun pozitif ve DF3 ekspresyonunun ise negatif bulunması üzerine, sonraki deneylerde DF3 primeri kullanı ldı. Yirmi sekiz hastanın 18'inde (%64) DF3 pozitif olarak saptandı. DF3 pozitifliği ile hastaların evresi, tümör büyüklüğü ( 2 cm), aksiller tutulum, ER/PR pozitifliği ve HG veya NG yüksekliği gibi parametreler arasında istatistiksel açıdan anlamlı bir fark bulunamadı.SONUÇ Erken evre meme kanserli hastalarda kemik iliğinde RT-PCR ile DF3 gen ekspresyonunun varlığının araştırılması yoluyla mikrometastaz saptanması tekniğinin, spesifikliğinin ve duyarlılığının yüksek olması nedeniyle etkin bir yöntem olduğu düşünülmektedir.

🔖

Cite This Article

YAZICI, H., DALAY, N., KEÇER, M., MÜSLÜMANOĞLU, M., İĞCİ, A., CABIOĞLU, N., YILDIRIM, E. O., BİTİŞİK, Ö., DAĞOĞLU, T., ÖZMEN, V. (2022). Detection of bone marrow micrometastases by reverse-transcriptase polymerase chain reaction (RT-PCR) in patients with early breast cancer. Türk Onkoloji Dergisi, Cilt: 23 - Sayı: 2, 55–62. https://ajindex.com/articles/639352

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Braun S, Pantel K, Müller P, Janni W, Hepp F, Kentenich CR, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000;342(8):525-33
  2. Gerber B, Krause A, Müller H, Richter D, Reimer T, Makovitzky J, et al. Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors. J Clin Oncol 2001;19(4):960-71
  3. Braun S, Cevatli BS, Assemi C, Janni W, Kentenich CR, Schindlbeck C, et al. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy. J Clin Oncol 2001;19(5):1468-75
  4. Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 2005;353(8):793-802
  5. Benoy IH, Elst H, Philips M, Wuyts H, Van Dam P, Scharpé S, et al. Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer. Clin Breast Cancer 2006;7(2):146-52
  6. Fehm T, Braun S, Muller V, Janni W, Gebauer G, Marth C, et al. A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation. Cancer 2006;107(5):885-92
  7. Gilbey AM, Burnett D, Coleman RE, Holen I. The detection of circulating breast cancer cells in blood. J Clin Pathol 2004;57(9):903-11
  8. Baker M, Gillanders WE, Mikhitarian K, Mitas M, Cole DJ. The molecular detection of micrometastatic breast cancer. Am J Surg 2003;186(4):351-8
  9. Martin VM, Siewert C, Scharl A, Harms T, Heinze R, Ohl S, et al. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS. Exp Hematol 1998;26(3):252-64
  10. Cabioglu N, Igci A, Yildirim EO, Aktas E, Bilgic S, Yavuz E, et al. An ultrasensitive tumor enriched flowcytometric assay for detection of isolated tumor cells in bone marrow of patients with breast cancer. Am J Surg 2002;184(5):414-7
  11. Ko Y, Grünewald E, Totzke G, Klinz M, Fronhoffs S, Gouni-Berthold I, et al. High percentage of false-positive results of cytokeratin 19 RT-PCR in blood: a model for the analysis of illegitimate gene expression. Oncology 2000;59(1):81-8
  12. JA Lopez Guercero, P. Bolufer-Gilabert M. Sanz Alanso, E. Barragan Gonzales, et al. Minima